US 11,806,558 B2
Body-worn air-treatment devices and methods of deactivating pathogens
Joseph W. Bingold, Portland, OR (US); Ian D. Gates, Portland, OR (US); David S. D'Ascenzo, Portland, OR (US); and Wyatt T. Weaver, Beaverton, OR (US)
Assigned to Clear Blew, Portland, OR (US)
Filed by Clear Blew, Portland, OR (US)
Filed on Jun. 23, 2021, as Appl. No. 17/356,254.
Claims priority of provisional application 63/044,966, filed on Jun. 26, 2020.
Prior Publication US 2021/0402045 A1, Dec. 30, 2021
Int. Cl. A62B 23/06 (2006.01); A61L 9/20 (2006.01); A61N 5/06 (2006.01); A61N 1/32 (2006.01); A62B 9/06 (2006.01)
CPC A62B 23/06 (2013.01) [A61L 9/20 (2013.01); A61N 1/32 (2013.01); A61N 5/0603 (2013.01); A61N 5/0624 (2013.01); A62B 9/06 (2013.01); A61L 2209/12 (2013.01); A61N 2005/0606 (2013.01); A61N 2005/0607 (2013.01); A61N 2005/0627 (2013.01); A61N 2005/0647 (2013.01); A61N 2005/0661 (2013.01); A61N 2005/0667 (2013.01)] 23 Claims
OG exemplary drawing
 
1. A body-worn air-treatment device (10), comprising:
a body (12) configured to be selectively coupled proximate a respiratory tract inlet (100) of a living individual (102); and
a pathogen-deactivating mechanism (14) supported by the body (12);
wherein the body (12) is configured to be selectively coupled to a nose (104) of the living individual (102) to position the pathogen-deactivating mechanism (14) to deactivate pathogens within the nose (104) of the living individual (102) as the pathogens pass the pathogen-deactivating mechanism (14) responsive to the living individual (102) breathing through the nose (104).